Global Animal Stem Cell Therapy Market Growth (Status and Outlook) 2025-2031

The global Animal Stem Cell Therapy market size is predicted to grow from US$ 286 million in 2025 to US$ 602 million in 2031; it is expected to grow at a CAGR of 13.2% from 2025 to 2031.

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

The animal stem cell therapy market is driven by increasing demand for advanced veterinary treatments, particularly for chronic and age-related conditions in pets and livestock. Stem cell therapies offer the potential to treat a variety of ailments such as osteoarthritis, tendon injuries, and organ degeneration, which are common in aging animals. As pet owners increasingly seek non-invasive, effective solutions for their animals' health problems, veterinary clinics and research institutions are advancing their stem cell therapy offerings. Furthermore, growing awareness of the benefits of regenerative medicine is helping to propel market growth in both companion animals and livestock sectors.

However, the market also faces several challenges. One of the key barriers is the high cost of stem cell therapies, which can limit accessibility for pet owners and smaller veterinary clinics. Additionally, the regulatory landscape for animal stem cell treatments is still evolving, which can create uncertainties around approval processes and standardization. There is also a lack of long-term clinical data supporting the effectiveness and safety of stem cell therapies, which can lead to hesitation among veterinarians and animal owners. These factors may slow down the widespread adoption of stem cell therapy in the veterinary field.

LPI (LP Information)' newest research report, the “Animal Stem Cell Therapy Industry Forecast” looks at past sales and reviews total world Animal Stem Cell Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal Stem Cell Therapy sales for 2025 through 2031. With Animal Stem Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal Stem Cell Therapy industry.

This Insight Report provides a comprehensive analysis of the global Animal Stem Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Animal Stem Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal Stem Cell Therapy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal Stem Cell Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal Stem Cell Therapy.

This report presents a comprehensive overview, market shares, and growth opportunities of Animal Stem Cell Therapy market by product type, application, key players and key regions and countries.

Segmentation by Type:
Dogs Stem Cell Therapy
Horses Stem Cell Therapy
Others

Segmentation by Application:
Veterinary Hospitals
Research Organizations

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Ardent Animal Health
VetStem
Medrego
Vetbiologics
Vetherapy
Celavet
Magellan Stem Cells
Animal General
Stem Care Company
Animal Cell Therapies
Cell Therapy Sciences
Animacel

Please note: The report will take approximately 2 business days to prepare and deliver.